Rapid Micro Biosystems (RPID) EBT Margin (2020 - 2026)
Rapid Micro Biosystems (RPID) posted EBT Margin of 178.29% for Q1 2026, down 61.14% sequentially from 110.65% in Q4 2025, and down 2207.0% YoY from 8.46% in Q1 2025.
Rapid Micro Biosystems (RPID) EBT Margin (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported EBT Margin for 7 years, with the latest figure at 178.29% in Q1 2026.
- Quarterly EBT Margin fell 2207.0% year-over-year to 178.29% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 145.69% (up 545.0% YoY) and the FY2025 annual result came in at 140.18%, up 2690.0% from the prior year.
- EBT Margin declined to 178.29% in Q1 2026 per RPID's latest filing, from 110.65% in the prior quarter.
- Over five years, EBT Margin peaked at 110.65% in Q4 2025 and troughed at 375.86% in Q4 2022.
- A 5-year average of 225.42% and a median of 189.83% in 2024 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2022 and 2023: EBT Margin sank 16229 bps in 2022, then surged 19969 bps in 2023.
- Over 5 years, EBT Margin stood at 375.86% in 2022, then soared by 53 bps to 176.17% in 2023, then jumped by 33 bps to 117.73% in 2024, then climbed by 6 bps to 110.65% in 2025, then sank by 61 bps to 178.29% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 178.29%, 110.65%, and 146.68% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 18.32% |
| 10 | Rapid Micro Biosystems | 82.91 Mn | 63.15 Mn | 1.21 Mn | -159.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -159.90% |
| Mar 31, 2026 | -178.29% |
| Dec 31, 2025 | -110.65% |
| Sep 30, 2025 | -146.68% |
| Jun 30, 2025 | -163.14% |
| Mar 31, 2025 | -156.22% |
| Dec 31, 2024 | -117.73% |
| Sep 30, 2024 | -148.74% |
| Jun 30, 2024 | -189.83% |
| Mar 31, 2024 | -237.37% |
| Dec 31, 2023 | -176.17% |
| Sep 30, 2023 | -217.77% |
| Jun 30, 2023 | -280.09% |
| Mar 31, 2023 | -275.67% |
| Dec 31, 2022 | -375.86% |
| Sep 30, 2022 | -344.63% |
| Jun 30, 2022 | -355.00% |
| Mar 31, 2022 | -358.34% |
| Dec 31, 2021 | -279.78% |
| Sep 30, 2021 | -361.89% |